-
Medical drugs: too big to fail
As my readers know, I’ve reported on a number of scandals concerning the toxicity of medical drugs and vaccines, including shocking death numbers in the US. These scandals are leaks from inside the National Security State. If you visit Wikileaks, Cryptome, Public Intelligence, and other similar sites, how many purely medical documents do you find…
-
Getting Involved!
How often are you asked for an opinion as to whether a particular test is worthwhile. Instances here might be vitamin D or more commonly, a coronary artery calcium score (CACS). The first cardiologist who used this, and openly discussed the benefits, was high-profile Dr. Ross Walker in Sydney. His colleagues really gave it to…
-
A Sensible Community Pharmacy & GP Collaboration
In a win for commonsense, a professional collaboration between community pharmacists and local GP’s coupled with a simultaneous a solution for a major public health problem, a mutually respectful system has been piloted in the County of Staffordshire in the UK. And patients involved in the pilot study have documented high levels of satisfaction, simply because…
-
Marketing Professional Services – Tactics & Strategies
Pharmacists are slowly coming to grips with the provision of professional services and are fleshing out suitable business models very cautiously. In part, this caution arises out of a sense of uncertainty because of the culture change that has to be embraced in converting what was previously an unstructured service (provided free of charge) to…
-
Are your patients involved in a clinical trial?
A 90-year-old patient of mine has given me two invitations sent to her by her surgery and signed by her GP, to participate in the STAREE trial. She has (one year ago) diagnosed early-onset Alzheimer’s and was unsuccessfully given one of the usual drugs which worsened her mental state. Interestingly, before that prescription was offered,…
-
Pathology Services – Better Options for Community Pharmacy
The recent pressure applied by the AMA and the RACGP in respect of the Sigma / Sonic Healthcare Project, to offer paid pathology tests through the AMCAL franchise must be bordering on unacceptable conduct under the Australian Trade Practices Act. The medical profession is looking and acting more like a cartel in every respect and…
-
Dementia – can we educate and reduce risk?
At the inaugural Swisse Preventative Health Symposium held in Melbourne last Friday, I was privileged to hear a fascinating address by Professor David Smith, Professor Emeritus, University of Oxford on “the role of nutrition in the prevention of cognitive impairment”. He classes dementia as a disease – not an inevitable part of ageing and certainly…
-
A4M Proposes a $1 trillion health cost save for US – why not Australia?
The American Academy for Anti-Ageing (A4M) is a medical group researching and treating the ageing process through utilising the concept of Integrative Medicine. They have come up with a simplified 10 point proposal designed to slash major costs from the health bill in the US – they say reductions of up to $1 trillion are…
-
Micro-practice – Future Direction for Pharmacy
I2P has long proposed that pharmacy attracts two types of consumers – customers and patients. A little reflection will resolve this issue because clearly, customers will be attracted to the more commercialised aspects of pharmacy that compete with retailing in general, and the reason why pharmacists see their major competitors as supermarkets and variety stores.…
-
Cell types like astrocytes regulate metabolic processes – Discovery of a brain sugar switch
Researchers at the Technical University of Munich (TUM) discovered that our brain actively takes sugar from the blood. Prior to this, researchers around the world had assumed that this was a purely passive process. An international team led by diabetes expert Matthias Tschöp reported in the journal ‘Cell’ that transportation of sugar into the brain…